MedTrace Logo

SLE Therapy Changes in Pregnancy and Relation to Pregnancy Outcome

NCT05176041 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 156

Last updated 2022-01-04

No results posted yet for this study

Summary

to review the changes to SLE medications during pregnancy including adherence and non-adherence to the medications and correlate these to the pregnancy outcome and post-partum course of the disease.

Conditions

  • Fetal Growth Retardation

Interventions

OTHER

Naser Al-Husban

observation

Sponsors & Collaborators

  • University of Jordan

    lead OTHER

Principal Investigators

  • Naser Al-Husban, A. Professor · The University of Jordan

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-11-30
Completion
2021-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05176041 on ClinicalTrials.gov